title: Re:Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.
authors.forename: P L
authors.initials: PL
authors.lastname: Lollini
authors.forename: P
authors.initials: P
authors.lastname: Nanni
authors.forename: C
authors.initials: C
authors.lastname: de Giovanni
authors.forename: G
authors.initials: G
authors.lastname: Nicoletti
authors.forename: L
authors.initials: L
authors.lastname: Landuzzi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005805:Genes, MHC Class I; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000235:genetics; D009363:Neoplasm Proteins / Q000187:drug effects / Q000235:genetics; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma